At a glance Looking toward the rest of 2022, capital markets organizations need to become familiar with what tokens can enable. At a high level, stablecoins serve as a bridge between traditional finance and DeFi; they can serve as a fiat on-ramp to DeFi and facilitate USD settlement outside of ... READ MORE >
Canada
3 priorities for insurers in the future of work: Spring 2022 outlook
At a glance A confluence of pressures is forcing many insurance companies to reinvent their traditional operating models. Insurers are modernizing their legacy systems, creating connected networks across the enterprise, and expanding their vendor partnerships, all while improving employees’ work ... READ MORE >
Automating compliance management can help firms offset rising costs: Spring 2022 outlook
At a glance Financial services firms are growing increasingly concerned over rising costs to maintain compliance amid constant regulatory changes. Emerging regulatory technologies offer many options to streamline regulatory compliance and risk management programs. Companies that embrace regtech ... READ MORE >
Clinical trials and life sciences services: Spring 2022 outlook
While there has been a downward trend in COVID-19 clinical trial starts, these trials maintain strong momentum into 2022. Enrollment remains at the top of the list of challenges facing clinical trials. Virtual trial companies have seen exponential growth over the past two quarters. Read about ... READ MORE >
Biopharma business outlook: Spring 2022
Drug approvals in 2021 continued at a pace consistent with prior years, but a large backlog of inspections is slowing some approvals. Cell and gene therapies investment is growing rapidly and promises substantial revenue growth in the coming years. Read about other sectors 2021 FDA approvals ... READ MORE >
The need for regulatory framework modernization: Spring 2022 medtech outlook
Having a well-defined pathway to quickly review and provide clearance for low-risk devices will help alleviate the backlog and shift resources to more critical and high-risk device applications. As the pace of innovation increases and the number of novel devices brought to market continues to grow, ... READ MORE >
Macroeconomic drivers for life sciences: Spring 2022 outlook
The three areas that middle market life sciences companies should pay specific attention to are supply chains, labor and capital markets. We anticipate a decreased appetite from private investors to pay high company valuations, but an uptick in the number of life sciences startups. This presents an ... READ MORE >
Life sciences industry outlook: Spring 2022
As the life sciences industry continues to experience growth and new scientific and operational opportunities, it also faces several challenges. Looking ahead, life sciences companies will encounter increased competition as the economy recovers. This includes competition for experienced and highly skilled ... READ MORE >
Canada runs a trade deficit as imports surge
Canada’s merchandise trade balance in December turned to a deficit after six consecutive monthly surpluses as imports of consumer goods surged and oil prices dropped, according to data released by Statistics Canada on Tuesday. Import and export values reached record highs last year because of higher ... READ MORE >
Although U.S. jobs report outshined Canada’s, Canadian outlook remains promising
Recent jobs reports have left some Canadians feeling out in the cold, especially when comparing numbers to our neighbors in the United States. However, as the initial shock of the Feb. 4 Canadian jobs report wears off, it’s clear that Canada is still firmly on the road to strong economic growth in 2022 ... READ MORE >